Molecular measurable residual disease before transplantation independently predicts survival and relapse risk in adult lysine methyltransferase 2a-rearranged acute myeloid leukemia.
Wang L, Chen Y, Zang M, Zhou J, Xiao M, Fu H, Mo X, Wang F, Han W, Zhang Y, Yan C, Wang Z, Han T, Lv M, Chen H, Chen Y, Chen Y, Wang J, Wang Y, Xu L, Liu K, Huang X, Zhang X.
Wang L, et al.
Cancer. 2025 Jan 15;131(2):e35717. doi: 10.1002/cncr.35717.
Cancer. 2025.
PMID: 39760486